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Abstract
Background: Several studies have examined the link between atrial fibrillation (AF) and various echocardiographic measures
of cardiac structure and function in whites and other racial groups but not in blacks. Exploring AF risk factors in blacks is
important given that the lower incidence of AF in this racial group despite higher risk factors, is not completely explained.
Methods: We examined the association of echocardiographic measures with AF incidence in 2283 blacks (64.5% women,
mean age 58.8 years) free of diagnosed AF and enrolled in the Jackson cohort of Atherosclerosis Risk in Communities (ARIC)
study, a prospective study of cardiovascular disease. Echocardiography was performed in 1993–1995, and incident AF was
determined by electrocardiograms at a follow-up study exam, hospitalization discharge codes and death certificates
through the end of 2009. Cox proportional hazards regression was used to estimate hazard ratios and 95% confidence
intervals for AF associated with the echocardiographic measures, adjusting for age, sex, and known AF risk factors.
Results: During an average follow-up of 13.5 years, 191 (8.4%) individuals developed AF. Left ventricular (LV) internal
diameter 2-D (diastole) and percent fractional shortening of LV diameter displayed a U-shaped relationship with risk of AF,
while left atrial diameter displayed a J-shaped nonlinear association. LV mass index was associated positively with AF. E/A
ratio ,0.7 or .1.5 and ejection fraction (EF ,50%) were also associated with higher AF risk. These measures improved risk
stratification for AF in addition to traditional risk factors, although not significantly {C-statistic of 0.767 (0.714–0.819) vs.
0.744 (0.691–0.797)}.
Conclusions: In a community-based population of blacks, echocardiographic measures of cardiac structure and function are
significantly associated with an increased risk of AF.
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Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia
in clinical practice, and its prevalence in the population is
increasing [1–3]. Along with traditional risk factors, underlying
structural and functional cardiac abnormalities such as chamber
dilatation, diastolic dysfunction, and valvular problems are
associated with higher AF risk [4–6]. Although blacks have a
higher prevalence of AF risk factors than whites [7–8], they
paradoxically have a lower risk for developing AF [2,9]. While
previous research has suggested that genetic factors might explain
some of this racial disparity [10], the mechanisms by which these
factors affect AF incidence still remain undetermined. Exploring
AF risk factors in blacks is important given that the lower
incidence of AF in this racial group despite higher risk factors is
not completely explained. Understanding racial differences in risk
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factors for AF may help improve understanding of mechanisms
and pathophysiology of the disease, prediction of AF in blacks, and
prevention and treatment of AF in all populations.
Echocardiography is a useful modality in evaluating underlying
structural and functional heart disease, and some studies have
shown differences in echocardiographic parameters between
whites and blacks [11]. The link between AF and various
echocardiographic markers of cardiac structure and function in
whites has been previously assessed [12–13]. To our knowledge,
no study has examined this association in a large cohort of blacks
with long term follow up for AF. Therefore, we examined
standardized echocardiographic measures performed at the
Jackson site of the Atherosclerosis Risk in Communities (ARIC)
study.
We hypothesized that echocardiographic measures of cardiac
structure and function, namely left atrial (LA) diameter, left
ventricular (LV) internal diameter, LV mass index, depressed LV
ejection fraction (LVEF), percent fractional shortening of 2D left
ventricular diameter (%FS), and early-to-late (E/A) diastolic filling




The ARIC Study has been previously described [14]. Briefly,
the ARIC study is a population-based prospective study of
cardiovascular disease (CVD) in a cohort of 15,792 individuals
aged 45 to 64 years at enrollment (1987–1989) sampled from four
US communities: Minneapolis, Minnesota; Washington County,
Maryland; Forsyth County, North Carolina; and Jackson,
Mississippi. Only blacks were recruited in Jackson. The baseline
visit (visit 1) and three triennial visits - 1990–1992 (visit 2), 1993–
1995 (visit 3), and 1996–1998 (visit 4), included interviews,
laboratory measurements, and clinic examinations. Participants
were also contacted annually by phone to obtain updated history.
Echocardiograms were only performed at visit 3 (1993–1995) in
the Jackson cohort (N = 2,622 black participants). Visit 3 was used
as the baseline for these analyses. The ARIC study protocols were
approved by the institutional review boards of each participating
center, and informed consent was obtained from each study
participant.
Echocardiography
Details of the design and quality control measures for
echocardiography have been described previously [15]. Echocar-
diographic parameters including 2D parasternal long axis LA
diameter, LV internal diameter, LV posterior wall thickness
(PWT), and interventricular septal thickness (IVST) were estimat-
ed at diastole. Relative wall thickness (RWT), defined as the ratio
of the PWT multiplied by 2 and the LVID in diastole, was also
calculated. The individual dimensions were used to estimate LV
mass according to the American Society of Echocardiography
(ASE) simplified cubed equation and were indexed by height2 to
normalize heart size to body size [16–17]. This permitted
categorization of individuals with increased LV mass index
(.95 g/m2 in females and .115 g/m2 in males), as either
concentric (RWT.0.42) or eccentric (RWT#0.42) hypertrophy.
Individuals with normal LV mass index were categorized as either
concentric remodeling (RWT.0.42), or normal geometry
(RWT#0.42). Qualitative two-dimensional left ventricular systolic
function (depressed {,50%} and normal) and Doppler mitral
valve inflow consisting of early (E) and late (A) peak velocity were
measured. Given that regional wall motion abnormalities were
Figure 1. Inclusion and exclusion criteria, Atherosclerosis Risk in Communities Study Jackson Cohort, 1993–1995.
doi:10.1371/journal.pone.0110111.g001
Echocardiography and AF in Blacks
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e110111
unlikely to be present in this population-derived cohort, %FS was
used to better evaluate the relationship between LV function and
AF. Doppler mitral inflow velocity time integral (VTI) of E wave
and A wave were also measured. Intra- and intersonographer and
intrareader correlation were excellent as assessed on a randomly
selected 2% sample of participants (for example, 0.94, 0.88 and
0.98 respectively, for LV mass).
Ascertainment of Incident Atrial Fibrillation
Only incident AF events occurring from visit 3 through
December 31, 2009 were considered. Individuals with AF
identified on or before visit 3 were excluded (N = 19). The
methods used for AF ascertainment have previously been
described in detail [9,18]. AF was identified through hospital
discharge codes (N = 182), electrocardiograms (ECG) performed at
visit 4 (N = 2), death certificates (N = 1), and both hospital
discharge codes and death certificates (N = 6). AF was identified
when International Classification of Diseases, ninth revision,
clinical modification (ICD-9-CM) code 427.31 or 427.32, or
ICD-10 code I48, was listed. Previous analyses within this
population have validated the diagnosis of incident AF based on
hospital discharges [9].
Standard supine 12-lead resting ECGs were recorded after a 12-
hour fast followed by a light snack and at least one hour after
smoking tobacco or ingestion of caffeine. All ECGs automatically
coded as AF were visually re-checked by a trained cardiologist to
confirm the diagnosis. Left ventricular hypertrophy (LVH) based
on Cornell voltage criteria [19], PR interval, and p wave indices
[20] were also recorded.
Measurement of other Covariates
At baseline (visit 3), weight, height, alcohol intake, cigarette
smoking, blood pressure, and antihypertensive medication use
were assessed using standardized methods [14]. Blood levels of
calcium, magnesium, phosphorus, and uric acid were measured at
visit 2. Definition of covariates are stated in the supplemental
material (File S1).
Statistical Analysis
Of 2,622 blacks in the ARIC Jackson cohort at visit 3, we
excluded 339 individuals (87 with missing or unreadable ECGs at
baseline, 19 with prevalent AF, and 233 with missing covariates).
The final sample included 2283 individuals. Due to technical
limitations, different echocardiographic measurements were avail-
able for diverse sets of individuals, resulting in a variable sample
size for each analysis (figure 1).
Cumulative incidence of AF by categories or quintiles of
echocardiographic parameters were estimated using Kaplan-
Meier curves. To estimate the association of echocardiographic
measures with time to incident AF, we calculated hazard ratios
(HRs) and 95% confidence intervals (CIs) using Cox proportional
hazards models. Person-years at risk were calculated from visit 3
until date of development of AF, death, loss to follow up, or end of
follow up (December, 2009), whichever occurred first. Initially, the
shape of the association between each continuous echocardio-
graphic measure and AF was explored using age- and sex-adjusted
restricted cubic spline models (Figure S1 in File S1). In order not to
assume linearity, LA diameter, LVID, %FS and LV mass index
were modeled as quintiles. Individuals were dichotomized into two
groups for LVEF: depressed (,50%) or normal. Mitral early-to-
late (E/A) diastolic filling velocity ratio was divided into 3
categories (,0.7, 0.7–1.5, and .1.5), with 0.7–1.5 used as the
reference point for all analyses. In an initial model, we adjusted for
age and sex. A second model additionally adjusted for the recently
described CHARGE-AF risk score [21], which consists of known
AF risk factors including age, height, weight, current smoking,
systolic blood pressure, diastolic blood pressure, anti-hypertensive
medications, diabetes, prevalent HF, and prevalent MI; and
estimates cumulative risk of AF over 5 years. The proportional
hazards assumption was tested using time interaction terms and
inspection of log-negative log survival curves. The assumption was
satisfied for all parameters except the E/A ratio. To address this
issue, follow-up for the E/A ratio analysis was split at the midpoint
into two time periods (0–8 years and .8 years to the end of follow-
up) at the midpoint of average follow up time, and HRs were
calculated for each period. Interactions by sex and HTN (a major
risk factor for AF) with these echocardiographic parameters were
examined. Interaction between LVH (by voltage criteria on ECG)
and LV diameter; and between LV mass index and RWT was also
examined.
Furthermore, we determined whether echocardiographic mea-
sures (modeled as continuous variables) improve the predictive
ability of the CHARGE AF risk score measuring improvement in
C-statistic for survival analysis over ten years [22]. To determine
whether individuals were reclassified correctly rather than due to
chance, we calculated the Net Reclassification Improvement
(NRI), using ,5.0%, 5.0%–10.0%, .10.0% risk as cutoff points
over ten years [23]. To avoid associations resulting from reverse
causation (AF leading to changes in echocardiographic parame-
ters) and to avoid including possible undetected prevalent AF cases
as new incident cases, we conducted a sensitivity analysis excluding
cases of AF occurring in the first 2 years after echocardiographic
measurements.
Finally, in secondary analyses, we added ECG measures of
increased LA size (defined as P wave duration $120 ms) and
ECG-LVH (Cornell voltage criteria) to models with echocardiog-
raphy measurements to determine whether ECG measures added
predictive value. The risk of AF based on the presence of
concentric hypertrophy, eccentric hypertrophy, or concentric
remodeling compared to normal geometry was determined. We
further adjusted covariate analyses models for PR interval,
calcium, magnesium, phosphorus, uric acid and alcohol use.
Analyses were performed using SAS, version 9.2; SAS Institute
Inc. All p values were 2-sided.
Results
Table 1 shows selected clinical, echocardiographic and elec-
trocardiographic measures of ARIC Jackson cohort participants at
visit 3 by incident AF status. In this population, individuals who
developed AF were more likely to be older males, to have higher
CHARGE-AF risk scores, larger LA, heavier LV, and more
systolic or diastolic dysfunction. They were also more likely to have
LVH based on Cornell voltage criteria and LA enlargement by P
wave indices.
During a total 30,826 person-years of follow-up (mean follow-up
13.5 years), we identified 191 incident cases of AF. After
adjustment for age and sex, longer LA diameter was associated
with an increased risk of AF in a J-shaped pattern (Figure S1 in
File S1). Compared to those in the 1st quintile, the HR (95% CI) of
AF for those in the 5th quintile was 2.46 (1.51–4.02), after
adjustment for the CHARGE-AF score. Similarly, LV mass index
was linearly associated with AF risk: HR (95% CI) comparing the
5th to the 1st quintile was 2.81 (1.61–4.91) after adjustment for the
CHARGE-AF score (Table 2). There was no significant interac-
tion between LV mass index and RWT (p = 0.54). On the other
hand, LV diameter showed a U-shaped relationship with incident
AF (Figure S1 in File S1), with increased risk among individuals
Echocardiography and AF in Blacks
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with small and those with large diameter. Risk was lowest at 2nd
quintile (HR 0.49, 95% CI 0.29–0.83 compared to the 1st quintile)
(Table 2, Model 2). %FS also showed a U-shaped relationship
with incident AF (Figure S1 in File S1), with risk lowest among
individuals in the third quintile (32.41–36.55) of %FS. Reduced
LVEF was associated with increased risk of AF (HR 3.46, 95% CI
1.88–6.36; Table 2, Model 2). Finally, diastolic dysfunction
based on an E/A ratio ,0.7 and .1.5 was also associated with
increased AF risk compared to an E/A ratio 0.7–1.5, though the
magnitude of the association differed over the entire follow-up
(Table 2). Additionally adjusting for educational level, HDL
cholesterol and digoxin use and incident HF and MI as time-
dependent covariates did not change the results (Table S1 in File
S1). Analyzing hazard ratios for AF by sex-specific quintiles did
not significantly change the results (Table S2 in File S1). Kaplan-
Meier curves showing cumulative incidence of AF by quintiles and
categories of echocardiographic parameters are shown in fig-
ure 2. Due to a small number of AF cases, quintiles were divided
into 3 groups in the Kaplan-Meier curves.
After adjustment for the CHARGE-AF risk score, LA
enlargement by P wave index on ECG was associated with a
35% increased risk for incident AF {HR (95% CI) = 1.35 (1.00–
1.82)}. Similarly, LVH using Cornell voltage criteria was also
associated with increased AF risk {HR (95% CI) = 2.28 (1.47–
3.53)} (Tables S3 and S4 in File S1). For all models examined,
there was no significant evidence of interaction by HTN or sex.
Table 1. Baseline characteristics with incident atrial fibrillation (AF) events through 2009 follow-up, Atherosclerosis Risk in
Communities Study Jackson Cohort, 1993–1995.
No AF during follow-up Incident AF
(n = 2092) (n = 191) P-Value
Clinical Measures*
Age, years 5965.6 6165.7 ,0.0001
Sex, male 729 (34.9) 82 (42.9) 0.03
Body Mass Index, kg/m2 30.466.3 32.166.8 0.0004
Current Smoking 399 (19.1) 54 (28.3) 0.002
High School Graduate 578 (27.6) 61 (31.9) ,0.0001
High-Density Cholesterol, mg/dL 57618.5 50615.6 ,0.0001
Systolic Blood Pressure, mmHg 130619.9 136622.2 ,0.0001
Diastolic Blood Pressure, mmHg 77610.4 76612.4 0.17
Anti-Hypertensive Medications 1041 (49.8) 138 (72.3) ,0.0001
Digoxin 30 (1.4) 11 (5.8) ,0.0001
Prevalent Diabetes 462 (22.1) 79 (41.4) ,0.0001
Prevalent Heart Failure 124 (5.9) 27 (14.1) ,0.0001
Prevalent Coronary Heart Disease 84 (4.0) 19 (10.0) 0.0002
Current alcohol use 622 (29.7) 63 (33) 0.15
CHARGE-AF Risk Score, % (5 years) 1.561.6 2.962.4 ,0.0001
Serum Calcium, mg/dL 9.5 (0.5) 9.5 (0.4) 0.92
Serum Magnesium, mEq/L 1.6 (0.2) 1.6 (0.2) 0.82
Serum Phosphorus, mmol/L 4.2 (0.4) 4.1 (0.5) 0.04
Uric Acid, mg/dL 6.6 (1.7) 7.2 (2.0) ,0.0001
Echocardiographic Measures*
Left Atrial Diameter, cm 3.360.5 3.660.6 ,0.0001
Left Ventricular Diameter (Diastole), cm 4.460.6 4.460.8 0.07
Left Ventricular Mass Index, g/m2 84.4624.8 99.4638.2 ,0.0001
Depressed Left Ventricular Ejection Fraction (EF ,50%) 39 (1.9) 13 (6.8) ,0.0001
Mitral Early-to-Late (E/A) Diastolic Filling Velocity Ratio ,0.0001
,0.7 154 (7.4) 28 (14.7)
.1.5 125 (6.0) 17 (8.9)
% Fractional Shortening of Left Ventricular Diameter 34.668.9 33.4610.5 0.10
Relative Wall Thickness 0.56 (0.13) 0.61 (0.16) ,0.0001
Electrocardiographic Measures*
Left Atrial Enlargement, P Wave Index 569 (27.8) 69 (37.1) 0.01
Left Ventricular Hypertrophy, Cornell Voltage Criteria 119 (5.8) 23 (12.3) 0.001
PR Interval, msec 172 (28) 171 (40) 0.69
* Data given as mean±SD or n (%).
doi:10.1371/journal.pone.0110111.t001
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There was no significant interaction between LVH (Cornell
voltage criteria) and LV diameter (P = 0.48). In a sensitivity
analysis, the above models were further adjusted for phosphorus,
magnesium, uric acid, calcium, alcohol use and PR interval on
ECG both individually and all in the same model. The results were
unchanged from those from the above models (data not shown).
Addition of individual echocardiographic variables to the
CHARGE AF score resulted in a modest, non-statistically
significant improvement in the C-statistic for prediction of AF
over a 10-year follow-up (Table 3). NRI for adding LA diameter
to the CHARGE-AF risk score was 0.12 (p = 0.01); other
echocardiographic variables did not improve reclassification over
ten years (Table 3). Addition of ECG variables to models
containing similar echocardiographic variables did not significant-
ly improve C statistic or NRI (Tables S5 and S6 in File S1).
When we examined all the echocardiographic variables in a
single model, C-statistic improved from 0.744 (0.691–0.797) to
0.767 (0.714–0.819). Addition of both echocardiographic and
ECG variables in the same model produced a similar result: C-
statistic 0.768 (0.715–0.821). Sample size for these analyses were
smaller (1773 individuals with 72 AF cases) as these were the only
individuals who had all the echocardiographic and ECG measures
available. In a sensitivity analysis excluding AF cases identified
during the first 2 years of follow-up, results were unchanged (data
not shown).
Finally, we examined four RWT-LV mass index groups to
assess their relationship to AF. After adjustment for age, sex and
Table 2. Hazard ratios (HR) and 95% confidence intervals (CI) for the association of echocardiographic parameters in quintiles with
time to incident atrial fibrillation (AF), ARIC Jackson Cohort, 1993–2009.
Parameter AF Cases | N Group/Quintile Model 1{ HR (95% CI) Model 2` HR (95% CI)
Left Atrial Diameter, cm 23 | 431 1.54–2.93 Reference Reference
28 | 432 .2.93–3.21 1.21 (0.70–2.10) 1.14 (0.66–1.98)
26 | 432 .3.21–3.46 1.11 (0.63–1.94) 1.05 (0.60–1.85)
40 | 431 .3.46–3.78 1.76 (1.05–2.94) 1.62 (0.97–2.71)
65 | 431 .3.78–5.18 3.06 (1.90–4.93) 2.46 (1.51–4.02)
P for Trend* ,0.0001 ,0.0001
Left Ventricular Mass Index, g/m2 17 | 402 27.91–65.03 Reference Reference
26 | 403 65.04–75.77 1.42 (0.77–2.61) 1.40 (0.76–2.58)
30 | 403 75.78–86.96 1.70 (0.94–3.08) 1.66 (0.91–3.00)
33 | 403 86.97–102.86 1.87 (1.04–3.36) 1.70 (0.95–3.06)
55 | 402 102.87–316.60 3.52 (2.04–6.08) 2.81 (1.61–4.91)
P for Trend* ,0.0001 0.0001
Left Ventricular Diameter (Diastole), cm 39 | 402 2.30–3.87 Reference Reference
21 | 403 .3.87–4.21 0.50 (0.29–0.85) 0.49 (0.29–0.83)
28 | 403 .4.21–4.48 0.72 (0.44–1.17) 0.68 (0.42–1.11)
34 | 403 .4.48–4.81 0.80 (0.50–1.28) 0.72 (0.45–1.15)
39 | 403 .4.81–7.19 1.03 (0.65–1.62) 0.78 (0.48–1.24)
P for Trend* 0.42 0.72
% Fractional Shortening of Left Ventricular Diameter 44 | 400 1.51–27.46 Reference Reference
32 | 401 27.47–32.40 0.69 (0.44–1.08) 0.79 (0.50–1.25)
23 | 401 32.41–36.55 0.45 (0.27–0.75) 0.50 (0.30–0.83)
29 | 401 36.56–41.75 0.62 (0.38–0.99) 0.71 (0.44–1.15)
33 | 401 41.76–78.21 0.65 (0.41–1.02) 0.72 (0.45–1.15)
P for Trend* 0.06 0.14
Left Ventricular Ejection Fraction (LVEF) 175 | 2223 Normal ($50%) Reference Reference
13 | 52 Low LVEF (,50%) 5.16 (2.91–9.14) 3.46 (1.88–6.36)
Mitral Early-to-Late (E/A) Diastolic Filling Velocity Ratio:
0–8 years
8 | 182 ,0.7 1.37 (0.64–2.93) 1.09 (0.50–2.37)
45 | 1775 0.7–1.5 Reference Reference
10 | 142 .1.5 3.56 (1.78–7.14) 3.59 (1.79–7.20)
.8 years to the end of follow-up 20 | 141 ,0.7 2.81 (1.69–4.67) 2.47 (1.47–4.15)
73 | 1603 0.7–1.5 Reference Reference
7 | 120 .1.5 1.51 (0.69–3.31) 1.51 (0.69–3.30)
* Linear trend in quintile number.
{Model 1 - adjusted for age and sex.
`Model 2 – adjusted for Model 1 + CHARGE risk score.
doi:10.1371/journal.pone.0110111.t002
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the CHARGE-AF risk score, concentric and eccentric hypertro-
phy were associated with increased AF risk, compared with normal
geometry, HR 3.17 (1.35–7.48) and 4.87 (1.37–17.35) respectively.
There was no increased risk of AF with concentric remodeling,
HR 1.72 (0.75–3.93).
Discussion
This population-based prospective study of blacks aged 51–70
years, found that echocardiographic measures of cardiac structure
and function are associated with an increased risk of AF,
independent of sex, lifestyles, clinical measures and chronic
diseases. We found that the association of some echocardiographic
measures (LA diameter, LV diameter, and %FS) with AF risk is
complex and non-linear. Specifically, LA diameter showed a J-
shaped association, with AF risk markedly increasing in the top
quintile (.3.78–5.18 cm). Several studies have shown that LA
diameter is a risk factor for AF [11,24,25]. It has also been shown
that LA diameter is smaller in blacks than whites, and that this
difference could contribute to lower AF risk in blacks [11,26].
Marcus et al. [11] found that mean LA diameter was 4.26 cm in
blacks vs. 4.33 cm in whites (p = 0.0026). Two prior reports using
data from the Framingham and Cardiovascular Health studies
have demonstrated a link between LA diameter and incident AF
mostly in whites [24–25]; however, non-linear associations were
not evaluated in these reports. Rosenberg et al. [12] evaluated
non-linear associations between diastolic parameters and AF also
in whites, but found only a linear association between LA diameter
and AF risk. Only one prior study has compared echocardio-
graphic parameters and risk of AF in blacks and whites [11],
however they only included 476 blacks with 6 AF cases. Since our
Table 3. C-Statistic and net reclassification index (NRI) for the association of echocardiographic parameters (as continuous
variables) with time to incident atrial fibrillation, ARIC Jackson Cohort, 1993–2009.
ECHO variable
C-statistic (95% CI) without
ECHO variable
C-statistic (95% CI) with
ECHO variable NRI (0.05,0.10) P-value
Left Atrial Diameter (cm) 0.718 (0.671–0.766) 0.741 (0.691–0.791) 0.12 0.01
Left Ventricular Diameter (Diastole) (cm) 0.740 (0.693–0.788) 0.750 (0.700–0.799) 0.03 0.41
Left Ventricular Mass Index (g/m2) 0.740 (0.693–0.787) 0.752 (0.706–0.799) 0.04 0.31
Depressed Left Ventricular Ejection Fraction
(LVEF ,50%)
0.726 (0.681–0.772) 0.739 (0.694–0.785) 0.03 0.36
Mitral Early-to-Late (E/A) Diastolic Filling Velocity Ratio 0.733 (0.683–0.783) 0.735 (0.685–0.785) 0.003 0.90
% Fractional Shortening of Left Ventricular Diameter 0.740 (0.692–0.787) 0.750 (0.705–0.795) 0.03 0.44
All Echo variables: n = 1773; AF cases = 72 0.744 (0.691–0.797) 0.767 (0.714–0.819)
doi:10.1371/journal.pone.0110111.t003
Figure 2. Kaplan-Meier curves for selected echocardiographic parameters, Atherosclerosis Risk in Communities Study Jackson
Cohort, 1993–2009. A: Left Atrial Diameter. B: Left Ventricular Diameter (Diastole). C: Left Ventricular Mass Index (g/m2). D: Left Ventricular Ejection
Fraction. E: E/A Ratio. F: % Fractional Shortening of the Left Ventricular Diameter.
doi:10.1371/journal.pone.0110111.g002
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study is the first to report this J-shaped relationship between LA
diameter and AF risk, it remains to be seen if this finding is
particular to blacks.
In a similar way, in the present study, LV diameter and %FS
both showed a U-shaped relationship with incident AF, with risk of
AF lowest at the midpoint of LV diameter and %FS 32.41–36.55.
The increased risk with smaller LV diameter may be explained by
the effect of hypertensive heart disease leading to a thicker left
ventricle and hence smaller internal diameter. In our analyses,
there was however no effect modification of LVH (Cornell voltage
criteria) on LV diameter. Both concentric hypertrophy (which can
be caused by pressure overload from hypertension), and eccentric
hypertrophy (caused by volume overload) were associated with
increased AF risk. %FS is a surrogate of cardiac contractility and
although it is dependent on preload, it is a long established method
of estimating LV function [37]. It only fails in individuals with
regional wall motion abnormalities which is not expected to be
present in this population-derived cohort. That there was a lower
risk of AF in patients with %FS 32.41–36.55, compared to those
with lower %FS is not surprising, as low LVEF (another marker of
reduction in myocardial function) was associated with lower AF
risk. Increased catecholamine release is associated with AF [38]. In
high catecholamine states, there may be hyperdynamic cardiac
function, and hence %FS may be increased. This might explain
the link between increased %FS and AF; hence the U shaped
relationship between %FS and AF. Also, LV mass index (a marker
of LVH), diastolic dysfunction measured by E/A ratio ,0.7 and .
1.5, and reduced LV systolic function were associated with
increased risk of AF [12,27,28]. These measures (except LV
diameter), both individually and together in a single model
improve risk stratification and discriminative ability over tradi-
tional risk factors for AF in blacks, although this improvement was
not statistically significant. Addition of ECG measures did not
significantly add to risk stratification. Although these measures are
associated with risk of AF in blacks, the associations between these
measures and AF in blacks are similar to those in whites
[11,12,24,25]; hence these measures alone are unlikely to explain
the racial differences found in AF.
The complex mechanisms underlying development of AF
remain incompletely understood. AF is thought to result from
presence of multiple wave fronts conducted to the ventricles from
the atria and requires triggers [29]. The regular impulses produced
by the sinus node to provide rhythmic contraction of the heart are
overwhelmed by these rapid randomly generated multiple wave
fronts [30–31]. There have been a few mechanisms suggested by
which echocardiographic markers of cardiac structure and
function may increase risk of developing AF. Increased LA size
has been thought to increase AF risk as a result of stretch of the
atrial appendage which leads to remodelling of the anatomy and
physiology of the left atrium and increases dispersion of atrial
refractoriness [25,32,33]. Impairment of LV end-diastolic filling
pressure and LA emptying caused by LV size, systolic and diastolic
dysfunction can also lead to development of AF by worsening
atrial structural remodeling. AF itself reduces atrial contractility,
contributing to atrial dilatation and more remodeling, thus
contributing to the progressive and perpetuating nature of this
arrhythmia [34]. HTN, CHD, age, inflammation and other risk
factors act as triggers and propagating factors directly influencing
these measures of cardiac structure and function increasing AF
risk. For example, age- and inflammation-related fibrosis can
cause increased atrial size, and HTN and CHD lead to increased
LV mass and cardiomyopathy. However, a positive association of
echocardiographic measures with AF persisted even after we
accounted for these traditional risk factors.
Our study has some limitations. First, we did not have
volumetric measures of atrial size. The limitations of assessment
of atrial size in M-mode or 2-D are widely recognized, and it is
accepted that volumetric measures are better. Second, markers of
HF (NT-proBNP), thyroid dysfunction (TSH) and renal failure
(eGFR), which are recognized risk factors for AF, were not
available. Hence, we could not adjust for them. However, we do
not expect that adjusting for these factors would have changed our
overall findings, since accounting for HF and other traditional risk
factors for AF did not completely explain the associations we
found. Third, most of our AF cases are identified due to
hospitalizations, which may not account for AF managed in
outpatient settings. Also, as AF is often transient, asymptomatic
patients may have been missed. Therefore, there is likely an under
ascertainment of incident AF cases. However, AF cases through
hospitalizations in ARIC have been validated [9,24]. Fourth, since
echocardiograms were performed between 1993 and 1995,
measures needed to properly classify diastolic function by current
ASE guidelines were not available. Prior studies, however, have
shown that E/A ratio of ,0.7 and .1.5 compared to 0.7-1.5 is a
marker for diastolic dysfunction and risk factor for CVD [35–36].
Also, while individuals with E/A ratio.1.5 could potentially have
normal filling, most in this category have demonstrated increased
CVD risk [35–36]. Since not all echocardiographic measures were
available for all individuals in the analysis, we were unable to
examine the overall relationship with AF and all measures in a
single model. Lastly, whites did not have echocardiograms
performed at visit 3, so we do not have direct racial comparisons.
Despite its limitations, this study is novel and has important
strengths, including the relatively large sample size, extended
follow-up, and availability of information on potential confound-
ers.
Conclusions
We have shown that echocardiographic measures of cardiac
structure and function in blacks are associated with an increased
risk of AF independent of traditional risk factors. Although these
measures individually and in a single model modestly improve risk
stratification and discriminative ability of AF in this population,
the only statistically significant improvement was for LA diameter.
Addition of ECG measures did not significantly add to risk
stratification. Further research is needed to determine if blacks at
increased risk based on echocardiographic measures can be
targeted with therapies to attempt to reduce incidence of AF.
Lastly, large prospective studies with direct racial comparisons of
associations of imaging modalities with AF are warranted.
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